Astex Pharmaceuticals Inc. (ASTX) announced Tuesday that the FDA has declined to approve Dacogen for Injection in the additional indication of acute myeloid leukemia in elderly patients who are not considered candidates for induction …
I could break down the financials and the charts of this stock for you, but the fact is Dollar General is uniquely placed amongst its rivals, and has shown great strides in improving both its top and bottom line. That's why its share price is …
Stochastic are also in buy mode. MACD is positive and above the signal line. You need to put this stock on your watchlist next week and pay special attention to the price and the volume action. ( click to enlarge ) Sonic Automotive Inc (NYSE ...
Votrient already is approved to treat patients with advanced kidney cancer. Bulletin Board stock Talon Therapeutics will go before an FDA advisory committee for its experimental treatment Marqibo for a type of leukemia. Update: The FDA …
Aster Pharmaceuticals, Tanger Factory Outlet and Petmed Express were among companies seeing big surges in options volume Monday. A look at the 10 companies seeing the biggest increase in options activity based on data compiled by …
Otsuka will acquire all of the outstanding shares of Astex for $8.50 per share in cash representing a 48% premium to the average closing stock price for the prior 30-day period. The principal attraction of Astex lies in Dacogen (decitabine) …
with a focus on pharmaceutical products for the treatment of diseases and nutraceutical products for the maintenance of …
with a focus on pharmaceutical products for the treatment of diseases and nutraceutical products for the maintenance of everyday health. For more information about Astex Pharmaceuticals, please visit http://www.astx.com